Secondary |
Hypertension |
14.9% |
Drug Use For Unknown Indication |
12.2% |
Pain |
12.2% |
Acute Myelomonocytic Leukaemia |
8.1% |
Prophylaxis |
6.8% |
Hyperparathyroidism Secondary |
5.4% |
Sedation |
5.4% |
Sepsis |
5.4% |
Depression |
4.1% |
Polyarthritis |
4.1% |
Mineral Supplementation |
2.7% |
Pancreatitis |
2.7% |
Pyrexia |
2.7% |
Renal Failure |
2.7% |
Systemic Lupus Erythematosus |
2.7% |
Thrombosis Prophylaxis |
2.7% |
Agitation |
1.4% |
Blood Bicarbonate Decreased |
1.4% |
Dehydration |
1.4% |
Dialysis |
1.4% |
|
Diarrhoea |
22.2% |
Stevens-johnson Syndrome |
22.2% |
Toxic Epidermal Necrolysis |
22.2% |
Weight Decreased |
22.2% |
Hypertonia |
11.1% |
|
Concomitant |
Product Used For Unknown Indication |
19.1% |
Osteoporosis |
10.9% |
Rheumatoid Arthritis |
10.3% |
Drug Use For Unknown Indication |
9.2% |
Hypertension |
8.9% |
Spondylitis |
5.7% |
Ankylosing Spondylitis |
5.6% |
Prophylaxis |
4.2% |
Asthma |
3.4% |
Essential Hypertension |
3.4% |
Pain |
3.1% |
Type 2 Diabetes Mellitus |
2.3% |
Osteoporosis Postmenopausal |
2.2% |
Osteoporosis Prophylaxis |
2.2% |
Crohn's Disease |
1.9% |
Atrial Fibrillation |
1.7% |
Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
Breast Cancer |
1.5% |
Depression |
1.5% |
Chronic Obstructive Pulmonary Disease |
1.4% |
|
Pericardial Effusion |
12.8% |
Thrombocytopenia |
10.1% |
Pathological Fracture |
9.2% |
Transaminases Increased |
7.3% |
Death |
6.4% |
Urinary Tract Infection |
6.4% |
Cardiomegaly |
5.5% |
Renal Failure |
4.6% |
Femur Fracture |
3.7% |
Hypoglycaemia |
3.7% |
Vertigo |
3.7% |
Vomiting |
3.7% |
Weight Decreased |
3.7% |
Hepatitis |
2.8% |
Hypertension |
2.8% |
Nausea |
2.8% |
Neoplasm Progression |
2.8% |
Nephrolithiasis |
2.8% |
Pyelonephritis |
2.8% |
Respiratory Failure |
2.8% |
|
Interacting |
Spinal Fracture |
28.6% |
Hypertension |
14.3% |
Osteoporotic Fracture |
14.3% |
Prophylaxis Against Gastrointestinal Ulcer |
14.3% |
Sleep Disorder |
14.3% |
Urinary Incontinence |
14.3% |
|
|